Arcutis Biotherapeutics (ARQT) Return on Capital Employed [ROCE] (2020 - 2026)
Arcutis Biotherapeutics (ARQT) reported Return on Capital Employed [ROCE] of 10.91% for Q2 2026, up 46.04 percentage points from -35.13% a year earlier and up 9.78 percentage points from the prior quarter.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends
For FY2025, Arcutis Biotherapeutics posted Return on Capital Employed [ROCE] of -4.68%, up 43.93 percentage points from FY2024.
- Return on Capital Employed [ROCE] has increased for three consecutive years, with a five-year change of +71.21 percentage points (FY2020 to FY2025).
- By year, Return on Capital Employed [ROCE] came in at -48.61% in FY2024 (+20.54 pp), -69.15% in FY2023 (+8.01 pp), -77.16% in FY2022 (-12.60 pp) and -64.56% in FY2021 (+11.33 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2020.
- Year over year, Return on Capital Employed [ROCE] has now increased in each of the last ten quarters, with an average year-over-year change of +34.23 percentage points over the last eight quarters.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2024 (a gain of 57.07 percentage points); the low point was Q2 2022 (a drop of 49.95 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 1.13% (Q1 2026), -4.49% (Q4 2025) and -14.60% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Arcutis Biotherapeutics | 3.16 Bn | 2.44 Bn | 118.92 Mn | 10.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.91% |
| Mar 31, 2026 | 1.13% |
| Dec 31, 2025 | -4.49% |
| Sep 30, 2025 | -14.60% |
| Jun 30, 2025 | -35.13% |
| Mar 31, 2025 | -47.50% |
| Dec 31, 2024 | -41.14% |
| Sep 30, 2024 | -67.73% |
| Jun 30, 2024 | -43.81% |
| Mar 31, 2024 | -54.17% |
| Dec 31, 2023 | -89.13% |
| Sep 30, 2023 | -93.74% |
| Jun 30, 2023 | -100.89% |
| Mar 31, 2023 | -83.55% |
| Dec 31, 2022 | -68.35% |
| Sep 30, 2022 | -82.83% |
| Jun 30, 2022 | -84.26% |
| Mar 31, 2022 | -65.99% |
| Dec 31, 2021 | -56.70% |
| Sep 30, 2021 | -43.31% |
API Access
Arcutis Biotherapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ARQT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();